(Q38233620)

31 August 2017

title

Management of chronic Giardia infection (English)

1 reference

31 August 2017

2

Kurt Hanevik

1 reference

31 August 2017

Angel A Escobedo

1

1 reference

31 August 2017

Pedro Almirall

series ordinal

3

1 reference

31 August 2017

Sérgio Cimerman

series ordinal

4

1 reference

31 August 2017

Maydel Alfonso

series ordinal

5

1 reference

31 August 2017

publication date

25 July 2014

1 reference

Expert Review of Anti-infective Therapy

31 August 2017

published in

1 reference

31 August 2017

volume

12

1 reference

31 August 2017

issue

9

1 reference

31 August 2017

page(s)

1143-1157

1 reference

Giardiasis: the ever-present threat of a neglected disease

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Extra-intestinal and long term consequences of Giardia duodenalis infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

High rate of fatigue and abdominal symptoms 2 years after an outbreak of giardiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Development of functional gastrointestinal disorders after Giardia lamblia infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Giardia and Cryptosporidium join the 'Neglected Diseases Initiative'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Giardiasis as a re-emerging infectious disease and its zoonotic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Giardiasis as a chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

The zoonotic transmission of Giardia and Cryptosporidium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Meta-analysis in assessment of the prevalence and annual incidence of Giardia spp. and Cryptosporidium spp. infections in humans in the Nordic countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Risk factors for sporadic giardiasis: a case-control study in southwestern England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Sexual transmission of giardiasis: a neglected route of spread?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Risk factors for Giardia lamblia infection in children in daycare centers in Havana, Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Assessment of the prevalence of intestinal parasitosis and associated risk factors among primary school children in Chencha town, Southern Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Infections in 252 patients with common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Childhood nephrotic syndrome in Cambodia: an association with gastrointestinal parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Prevalence of intestinal parasites in Cuban acquired immunodeficiency syndrome (AIDS) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

A longitudinal study of Giardia lamblia infection in north-east Brazilian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Longitudinal study of giardiasis in three day care centres of Havana City

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Co-infection with Ascaris lumbricoides modulates protective immune responses against Giardia duodenalis in school Venezuelan rural children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Giardiasis--why do the symptoms sometimes never stop?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Giardia immunity--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Giardia duodenalis arginine deiminase modulates the phenotype and cytokine secretion of human dendritic cells by depletion of arginine and formation of ammonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Giardia duodenalis: dendritic cell defects in IL-6 deficient mice contribute to susceptibility to intestinal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Giardiasis: analysis of histological changes in biopsy specimens of 80 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Host parasite interactions and pathophysiology in Giardia infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Effect of chronic Giardia lamblia infection on epithelial transport and barrier function in human duodenum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Giardia duodenalis assemblage-specific induction of apoptosis and tight junction disruption in human intestinal epithelial cells: effects of mixed infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Common coinfections of Giardia intestinalis and Helicobacter pylori in non-symptomatic Ugandan children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Giardia/giardiasis - a perspective on diagnostic and analytical tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Giardiasis: a histologic analysis of 567 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Diagnostic value of endoscopy for the diagnosis of giardiasis and other intestinal diseases in patients with persistent diarrhea from tropical or subtropical areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Commercial assay for detection of Giardia lamblia and Cryptosporidium parvum antigens in human fecal specimens by rapid solid-phase qualitative immunochromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Evaluation of seven commercial antigen detection tests for Giardia and Cryptosporidium in stool samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Real-time PCR assay for detection and genotype differentiation of Giardia lamblia in stool specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Real-time PCR for the detection of Giardia lamblia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Sensitive PCR-restriction fragment length polymorphism assay for detection and genotyping of Giardia duodenalis in human feces

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Molecular epidemiology of giardiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Histopathology in Giardiasis: A Correlation with Diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Pathophysiology of enteric infections with Giardia duodenalius

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Host immunity and pathogen strain contribute to intestinal disaccharidase impairment following gut infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

ACG clinical guidelines: diagnosis and management of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Progress, problems, and perspectives in diagnosis and treatment of Whipple's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Microscopic colitis. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Microscopic colitis: epidemiology, pathophysiology, diagnosis and current management-an update 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Postinfectious functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Postinfectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Effects of albendazole/metronidazole or tetracycline/folate treatments on persisting symptoms after Giardia infection: a randomized open clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Rapid reinfection by Giardia lamblia after treatment in a hyperendemic Third World community

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Illness and reservoirs associated with Giardia lamblia infection in rural Egypt: the case against treatment in developing world environments of high endemicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Giardiasis: a pharmacotherapy review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

A systematic review and meta-analysis of the association between Giardia lamblia and endemic pediatric diarrhea in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

21 January 2018

Treatment of giardiasis.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Efficacy of antigiardial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Evidence behind the WHO guidelines: Hospital care for children: What is the most appropriate treatment for giardiasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Giardiasis, drug resistance, and new target discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

New approaches to the treatment of giardiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Efficacy of 5-nitroimidazoles for the treatment of giardiasis: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

A systematic review on the treatment of giardiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Tinidazole: a nitroimidazole antiprotozoal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

The treatment of giardiasis in children: single-dose tinidazole compared with 3 days of nitazoxanide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

21 January 2018

Prepatency of giardiasis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Treatment of patients with refractory giardiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Furazolidone-induced mood disorder during the treatment of refractory giardiasis in a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

A family cluster of giardiasis with variable treatment responses: refractory giardiasis in a family after a trip to India

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Drug targets and mechanisms of resistance in the anaerobic protozoa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Drug resistance and Giardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Quinacrine-induced psychiatric disturbances in a child with common variable immunodeficiency and chronic giardiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Sensitivity in vitro of Giardia intestinalis to dyadic combinations of azithromycin, doxycycline, mefloquine, tinidazole and furazolidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Pharmacokinetic investigation of albendazole and praziquantel in Thai children infected with Giardia intestinalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Synergistic effect of febantel and pyrantel embonate in elimination of Giardia in a gerbil model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Short course combination therapy for giardiasis after nitroimidazole failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Synergic effect of metronidazole and pyrantel pamoate on Giardia lamblia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Comparison of chloroquine, albendazole and tinidazole in the treatment of children with giardiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

A tale of two parasites: the comparative epidemiology of cryptosporidiosis and giardiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

Sensitivity of a Giardia antigen test in persistent giardiasis following an extensive outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.942283

10.1586/14787210.2014.942283

21 January 2018

Identifiers

DOI

1 reference

release_r3e5pjk5jnbwhpxtltpoyyuglu

31 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/r3e5pjk5jnbwhpxtltpoyyuglu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference